These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7534293)

  • 1. E2F-1 and a cyclin-like DNA repair enzyme, uracil-DNA glycosylase, provide evidence for an autoregulatory mechanism for transcription.
    Walsh MJ; Shue G; Spidoni K; Kapoor A
    J Biol Chem; 1995 Mar; 270(10):5289-98. PubMed ID: 7534293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcription factor E2F-1 is a downstream target of RB action.
    Qin XQ; Livingston DM; Ewen M; Sellers WR; Arany Z; Kaelin WG
    Mol Cell Biol; 1995 Feb; 15(2):742-55. PubMed ID: 7823942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Arnold W; Daniel PT; Mapara MY; Grinstein E; Royer HD; Dörken B
    J Exp Med; 1996 Mar; 183(3):1205-13. PubMed ID: 8642262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase.
    Haug T; Skorpen F; Aas PA; Malm V; Skjelbred C; Krokan HE
    Nucleic Acids Res; 1998 Mar; 26(6):1449-57. PubMed ID: 9490791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle.
    Oswald F; Dobner T; Lipp M
    Mol Cell Biol; 1996 May; 16(5):1889-95. PubMed ID: 8628255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression.
    Johnson DG; Ohtani K; Nevins JR
    Genes Dev; 1994 Jul; 8(13):1514-25. PubMed ID: 7958836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of the cyclin E gene by transcription factor E2F1.
    Ohtani K; DeGregori J; Nevins JR
    Proc Natl Acad Sci U S A; 1995 Dec; 92(26):12146-50. PubMed ID: 8618861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
    Hsiao KM; McMahon SL; Farnham PJ
    Genes Dev; 1994 Jul; 8(13):1526-37. PubMed ID: 7958837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.
    Kundu M; Srinivasan A; Pomerantz RJ; Khalili K
    J Virol; 1995 Nov; 69(11):6940-6. PubMed ID: 7474112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription.
    Margolis MJ; Pajovic S; Wong EL; Wade M; Jupp R; Nelson JA; Azizkhan JC
    J Virol; 1995 Dec; 69(12):7759-67. PubMed ID: 7494286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDP/cut is the DNA-binding subunit of histone gene transcription factor HiNF-D: a mechanism for gene regulation at the G1/S phase cell cycle transition point independent of transcription factor E2F.
    van Wijnen AJ; van Gurp MF; de Ridder MC; Tufarelli C; Last TJ; Birnbaum M; Vaughan PS; Giordano A; Krek W; Neufeld EJ; Stein JL; Stein GS
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11516-21. PubMed ID: 8876167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for a bent DNA structure in E2F-mediated transcription activation.
    Cress WD; Nevins JR
    Mol Cell Biol; 1996 May; 16(5):2119-27. PubMed ID: 8628278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1.
    Wu CL; Classon M; Dyson N; Harlow E
    Mol Cell Biol; 1996 Jul; 16(7):3698-706. PubMed ID: 8668186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional roles of E2F in cell cycle regulation.
    Fan J; Bertino JR
    Oncogene; 1997 Mar; 14(10):1191-200. PubMed ID: 9121768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E2F-mediated growth regulation requires transcription factor cooperation.
    van Ginkel PR; Hsiao KM; Schjerven H; Farnham PJ
    J Biol Chem; 1997 Jul; 272(29):18367-74. PubMed ID: 9218478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of p16 in the E2F-dependent thymidine kinase regulation.
    Hengstschläger M; Hengstschläger-Ottnad E; Pusch O; Wawra E
    Oncogene; 1996 Apr; 12(8):1635-43. PubMed ID: 8622883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.